Merck Announces Results of REVEAL Outcomes Study of Anacetrapib, Investigational Medicine for Cardiovascular Disease

KENILWORTH, N.J.--(BUSINESS WIRE) August 29, 2017 --Merck (NYSE:MRK), known as MSD outside the U.S. and Canada, and researchers in the Clinical Trial Service Unit at the University of Oxford, today announced the publication and presentation of...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials